Flexion Therapeutics (FLXN) Stock Cash Flow
NASDAQ:FLXN - Nasdaq -
| TTM (2021-9-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -100.73M | -113.71M | -149.77M | -169.66M | -137.48M | |||
| Depreciation Amortization | 1.97M | 1.70M | 1.06M | 1.71M | 2.01M | |||
| Change In Working Capital | 1.57M | 8.83M | -25.54M | -14.20M | 11.80M | |||
| Interest Paid | 10.85M | 10.41M | 8.05M | 7.87M | 5.08M | |||
| Other non cash items | 35.99M | 32.62M | 25.50M | 21.73M | 15.84M | |||
| OPERATING CASH FLOW | -61.18M | -70.56M | -148.76M | -160.42M | -107.83M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.95M | -10.07M | -3.89M | -850.00K | -2.15M | |||
| Other Investing Activity | 51.09M | -12.69M | 118.66M | 126.44M | -116.53M | |||
| INVESTING CASH FLOW | 48.14M | -22.76M | 114.76M | 125.58M | -118.67M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 18.13M | 20.00M | 25.63M | -10.00M | 192.92M | |||
| Stock Issued/Repurchased | 3.45M | 99.18M | 3.55M | 3.68M | 137.54M | |||
| Other Financing Activity | -335.00K | -400.00K | -160.00K | N/A | -6.96M | |||
| FINANCING CASH FLOW | 21.24M | 118.78M | 29.02M | -6.33M | 323.50M | |||
| CHANGE IN CASH | 8.20M | 25.46M | -4.98M | -41.17M | 97.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -61.18M | -70.56M | -148.76M | -160.42M | -107.83M | |||
| Capital Expenditure | -2.95M | -10.07M | -3.89M | -850.00K | -2.15M | |||
| FREE CASH FLOW | -64.13M | -80.63M | -152.65M | -161.27M | -109.98M | |||
All data in USD